514 related articles for article (PubMed ID: 34048852)
1. Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS.
van der Made CI; Potjewijd J; Hoogstins A; Willems HPJ; Kwakernaak AJ; de Sevaux RGL; van Daele PLA; Simons A; Heijstek M; Beck DB; Netea MG; van Paassen P; Elizabeth Hak A; van der Veken LT; van Gijn ME; Hoischen A; van de Veerdonk FL; Leavis HL; Rutgers A
J Allergy Clin Immunol; 2022 Jan; 149(1):432-439.e4. PubMed ID: 34048852
[TBL] [Abstract][Full Text] [Related]
2. Case Report: Genetic Double Strike: VEXAS and TET2-Positive Myelodysplastic Syndrome in a Patient With Long-Standing Refractory Autoinflammatory Disease.
Lötscher F; Seitz L; Simeunovic H; Sarbu AC; Porret NA; Feldmeyer L; Borradori L; Bonadies N; Maurer B
Front Immunol; 2021; 12():800149. PubMed ID: 35126364
[TBL] [Abstract][Full Text] [Related]
3. Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population.
Beck DB; Bodian DL; Shah V; Mirshahi UL; Kim J; Ding Y; Magaziner SJ; Strande NT; Cantor A; Haley JS; Cook A; Hill W; Schwartz AL; Grayson PC; Ferrada MA; Kastner DL; Carey DJ; Stewart DR
JAMA; 2023 Jan; 329(4):318-324. PubMed ID: 36692560
[TBL] [Abstract][Full Text] [Related]
4. Somatic Mutations in
Beck DB; Ferrada MA; Sikora KA; Ombrello AK; Collins JC; Pei W; Balanda N; Ross DL; Ospina Cardona D; Wu Z; Patel B; Manthiram K; Groarke EM; Gutierrez-Rodrigues F; Hoffmann P; Rosenzweig S; Nakabo S; Dillon LW; Hourigan CS; Tsai WL; Gupta S; Carmona-Rivera C; Asmar AJ; Xu L; Oda H; Goodspeed W; Barron KS; Nehrebecky M; Jones A; Laird RS; Deuitch N; Rowczenio D; Rominger E; Wells KV; Lee CR; Wang W; Trick M; Mullikin J; Wigerblad G; Brooks S; Dell'Orso S; Deng Z; Chae JJ; Dulau-Florea A; Malicdan MCV; Novacic D; Colbert RA; Kaplan MJ; Gadina M; Savic S; Lachmann HJ; Abu-Asab M; Solomon BD; Retterer K; Gahl WA; Burgess SM; Aksentijevich I; Young NS; Calvo KR; Werner A; Kastner DL; Grayson PC
N Engl J Med; 2020 Dec; 383(27):2628-2638. PubMed ID: 33108101
[TBL] [Abstract][Full Text] [Related]
5. Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS.
Ferrada MA; Sikora KA; Luo Y; Wells KV; Patel B; Groarke EM; Ospina Cardona D; Rominger E; Hoffmann P; Le MT; Deng Z; Quinn KA; Rose E; Tsai WL; Wigerblad G; Goodspeed W; Jones A; Wilson L; Schnappauf O; Laird RS; Kim J; Allen C; Sirajuddin A; Chen M; Gadina M; Calvo KR; Kaplan MJ; Colbert RA; Aksentijevich I; Young NS; Savic S; Kastner DL; Ombrello AK; Beck DB; Grayson PC
Arthritis Rheumatol; 2021 Oct; 73(10):1886-1895. PubMed ID: 33779074
[TBL] [Abstract][Full Text] [Related]
6. [VEXAS syndrome : when do we have to consider it ?].
Coattrenec Y; De Lorenzi C; Samii K; Serratrice J; Seebach JD
Rev Med Suisse; 2022 Apr; 18(776):652-659. PubMed ID: 35385616
[TBL] [Abstract][Full Text] [Related]
7. Looking beyond VEXAS: Coexistence of undifferentiated systemic autoinflammatory disease and myelodysplastic syndrome.
Oganesyan A; Hakobyan Y; Terrier B; Georgin-Lavialle S; Mekinian A
Semin Hematol; 2021 Oct; 58(4):247-253. PubMed ID: 34802547
[TBL] [Abstract][Full Text] [Related]
8. Clinical Heterogeneity of the VEXAS Syndrome: A Case Series.
Koster MJ; Kourelis T; Reichard KK; Kermani TA; Beck DB; Cardona DO; Samec MJ; Mangaonkar AA; Begna KH; Hook CC; Oliveira JL; Nasr SH; Tiong BK; Patnaik MM; Burke MM; Michet CJ; Warrington KJ
Mayo Clin Proc; 2021 Oct; 96(10):2653-2659. PubMed ID: 34489099
[TBL] [Abstract][Full Text] [Related]
9. VEXAS syndrome: A review of cutaneous findings and treatments in an emerging autoinflammatory disease.
Saad AJ; Patil MK; Cruz N; Lam CS; O'Brien C; Nambudiri VE
Exp Dermatol; 2024 Mar; 33(3):e15050. PubMed ID: 38469984
[TBL] [Abstract][Full Text] [Related]
10. UBA1 and DNMT3A mutations in VEXAS syndrome. A case report and literature review.
Shaukat F; Hart M; Burns T; Bansal P
Mod Rheumatol Case Rep; 2022 Jan; 6(1):134-139. PubMed ID: 34480172
[TBL] [Abstract][Full Text] [Related]
11. Characteristic bone marrow findings in patients with UBA1 somatic mutations and VEXAS syndrome.
Patel N; Dulau-Florea A; Calvo KR
Semin Hematol; 2021 Oct; 58(4):204-211. PubMed ID: 34802541
[TBL] [Abstract][Full Text] [Related]
12. VEXAS syndrome.
Nakajima H; Kunimoto H
Int J Hematol; 2024 May; ():. PubMed ID: 38819628
[TBL] [Abstract][Full Text] [Related]
13. Successful azacitidine therapy for myelodysplastic syndrome associated with VEXAS syndrome.
Kataoka A; Mizumoto C; Kanda J; Iwasaki M; Sakurada M; Oka T; Fujimoto M; Yamamoto Y; Yamashita K; Nannya Y; Ogawa S; Takaori-Kondo A
Int J Hematol; 2023 Jun; 117(6):919-924. PubMed ID: 36641501
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive morphologic characterization of bone marrow biopsy findings in a large cohort of patients with VEXAS syndrome: A single-institution longitudinal study of 111 bone marrow samples from 52 patients.
Olteanu H; Patnaik M; Koster MJ; Herrick JL; Chen D; He R; Viswanatha D; Warrington KJ; Go RS; Mangaonkar AA; Kourelis T; Hines A; Gibson SE; Peterson JF; Reichard KK
Am J Clin Pathol; 2024 Jun; 161(6):609-624. PubMed ID: 38413044
[TBL] [Abstract][Full Text] [Related]
15. UBA1 Variations in Neutrophilic Dermatosis Skin Lesions of Patients With VEXAS Syndrome.
Zakine E; Schell B; Battistella M; Vignon-Pennamen MD; Chasset F; Mahévas T; Cordoliani F; Adès L; Sébert M; Delaleu J; Jachiet M; Lepelletier C; Lemaire P; Chauvel C; Dhouaieb B; Kim R; Cassius C; Georgin-Lavialle S; Mekinian A; Bagot M; Braun T; Rousset L; Begon E; de Masson A; Fenaux P; Clappier E; Bouaziz JD
JAMA Dermatol; 2021 Nov; 157(11):1349-1354. PubMed ID: 34495287
[TBL] [Abstract][Full Text] [Related]
16. VEXAS syndrome.
Grayson PC; Patel BA; Young NS
Blood; 2021 Jul; 137(26):3591-3594. PubMed ID: 33971000
[TBL] [Abstract][Full Text] [Related]
17. Paradigm shift in monogenic autoinflammatory diseases and systemic vasculitis: The VEXAS syndrome.
Hernández-Rodríguez J; Mensa-Vilaró A; Aróstegui JI
Med Clin (Barc); 2022 Nov; 159(10):489-496. PubMed ID: 36049972
[TBL] [Abstract][Full Text] [Related]
18. Vacuoles in neutrophil precursors in VEXAS syndrome: diagnostic performances and threshold.
Lacombe V; Prevost M; Bouvier A; Thépot S; Chabrun F; Kosmider O; Lacout C; Beucher A; Lavigne C; Geneviève F; Urbanski G
Br J Haematol; 2021 Oct; 195(2):286-289. PubMed ID: 34340250
[No Abstract] [Full Text] [Related]
19. Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients.
Georgin-Lavialle S; Terrier B; Guedon AF; Heiblig M; Comont T; Lazaro E; Lacombe V; Terriou L; Ardois S; Bouaziz JD; Mathian A; Le Guenno G; Aouba A; Outh R; Meyer A; Roux-Sauvat M; Ebbo M; Zhao LP; Bigot A; Jamilloux Y; Guillotin V; Flamarion E; Henneton P; Vial G; Jachiet V; Rossignol J; Vinzio S; Weitten T; Vinit J; Deligny C; Humbert S; Samson M; Magy-Bertrand N; Moulinet T; Bourguiba R; Hanslik T; Bachmeyer C; Sebert M; Kostine M; Bienvenu B; Biscay P; Liozon E; Sailler L; Chasset F; Audemard-Verger A; Duroyon E; Sarrabay G; Borlot F; Dieval C; Cluzeau T; Marianetti P; Lobbes H; Boursier G; Gerfaud-Valentin M; Jeannel J; Servettaz A; Audia S; Larue M; Henriot B; Faucher B; Graveleau J; de Sainte Marie B; Galland J; Bouillet L; Arnaud C; Ades L; Carrat F; Hirsch P; Fenaux P; Fain O; Sujobert P; Kosmider O; Mekinian A; ;
Br J Dermatol; 2022 Mar; 186(3):564-574. PubMed ID: 34632574
[TBL] [Abstract][Full Text] [Related]
20. Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS syndrome) with prominent supraglottic larynx involvement: a case-based review.
Guerrero-Bermúdez CA; Cardona-Cardona AF; Ariza-Parra EJ; Arostegui JI; Mensa-Vilaro A; Yague J; Vásquez G; Muñoz-Vahos CH
Clin Rheumatol; 2022 Nov; 41(11):3565-3572. PubMed ID: 35986821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
